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Abstract
Background: Studies of chronic diseases are associated with a financial burden on households. We aimed to
determine if survivors of acute coronary syndrome (ACS) experience household economic burden and to quantify
any potential burden by examining level of economic hardship and factors associated with hardship.
Methods: Australian patients admitted to hospital with ACS during 2-week period in May 2012, enrolled in SNAPSHOT
ACS audit and who were alive at 18 months after index admission were followed-up via telephone/paper survey.
Regression models were used to explore factors related to out-of-pocket expenses and economic hardship.
Results: Of 1833 eligible patients at baseline, 180 died within 18 months, and 702 patients completed the survey. Mean
out-of-pocket expenditure (n = 614) in Australian dollars was A$258.06 (median: A$126.50) per month. The average
spending for medical services was A$120.18 (SD: A$310.35) and medications was A$66.25 (SD: A$80.78). In total, 350
(51 %) of patients reported experiencing economic hardship, 78 (12 %) were unable to pay for medical services and 81
(12 %) could not pay for medication. Younger age (18–59 vs ≥80 years (OR): 1.89), no private health insurance (OR: 2.04),
pensioner concession card (OR: 1.80), residing in more disadvantaged area (group 1 vs 5 (OR): 1.77), history of CVD
(OR: 1.47) and higher out-of-pocket expenses (group 4 vs 1 (OR): 4.57) were more likely to experience hardship.
Conclusion: Subgroups of ACS patients are experiencing considerable economic burden in Australia. These
findings provide important considerations for future policy development in terms of the cost of recommended
management for patients.
Keywords: Acute coronary syndrome, Household economic hardship, Out-of-pocket expenditure, Financial
burden
Background
Acute coronary syndrome (ACS) which includes acute
myocardial infarction (MI) and unstable angina (UA) has
a high incidence globally [1]. More than 2.5 million
hospitalizations are due to ACS worldwide [2]. In
Australia, the number of ACS hospitalizations has
increased 79 % from 1993 to 2008 for acute MI and
33 % for UA, resulting in 95,000 hospitalizations in 2008
[3]. The direct health care system costs associated with
ACS were estimated to be A$1.8 billion and total
economic cost of A$17.9 billion in 2009 [4]. As the
population ages, grows and the projections for ACS
hospitalizations rising, the economic burden, not only to
health systems but also to individuals and their house-
holds, will inevitably become more pronounced. To
better control the potentially substantial economic bur-
den, it is important to understand the current economic
wellbeing of the patients. However, this has not been
readily explored, especially in high income countries.
Recommended treatment for patients with ACS in-
cludes coronary revascularization, adherence to long-term
therapies such as: antiplatelet agent(s), beta-blocker,
angiotensin-converting enzyme inhibitor, statin and other
therapies as appropriate, cardiac rehabilitation services
and follow-up appointments with treating physicians [1].
Australian patients benefit from the national health insur-
ance system, Medicare. It can provide ‘bulk billing’, a
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payment option where a doctor accepts the Medicare
benefit as full payment and does not charge patients an
extra fee, co-payment system for medical services and
listed medications, and further benefits for those with high
out-of-pocket health costs (Medicare Safety Net) [5–8].
Despite this, only 72 % of patients continue prescribed
medications and 34 % complete cardiac rehabilitation pro-
gram after hospital discharge [9, 10]. The rate of bulk bill-
ing for a specialist appointment is also as low as 29 % [11].
Optimal ACS management involves long-term medical
therapies and attendance at programs and appointments
to prevent secondary events. Even with government
schemes to assist, treatment of ACS may impose an
economic burden on patients and contribute to a decrease
in the use of medications and health services in general.
Recent research in other chronic diseases in Australia
including stroke, chronic obstructive pulmonary disease
(COPD) and chronic kidney disease (CKD) indicates that
patients experience a significant household economic
impact related to their disease condition which has
negative consequences for patient outcomes in terms of
longer-term treatment adherence and quality of life
[12, 13]. There are various reasons for non-adherence
to treatment, such as poor understanding of their
disease state, ineffective communication between the
clinician and the patient, and financial reasons [14].
For ACS survivors, the impact of living with heart
disease on the economic well-being of the household
remains unclear. Therefore, the aim of this research
is to describe the out-of-pocket expenditure associ-
ated with ACS and investigate the consequent house-
hold economic burden.
Methods
Patient cohort
This study was a subgroup analysis of the Australian
SNAPSHOT ACS audit. Details relating to the method-
ology for the broader SNAPSHOT ACS study has been
published previously [15]. In brief, all hospitals receiving
patients with suspected ACS (including public and private,
metropolitan and rural) were identified from their medical
records and invited to participate. Patients were eligible to
participate in the study if they were admitted overnight
with a suspected/confirmed ACS event between May 14th
and 27th, 2012. Patients who survived to 18 months after
their index admission were followed-up. For the Australian
cohort, mortality data at 18 months after index admission
was collected via data linkage using the National Death
Index. For this sub-study, the household economic status
as a part of the 18-month follow-up was collected from
two Australian States, New South Wales (NSW) and
Queensland (QLD). Human Research Ethics Committee
(HREC) approvals were sought for each hospital, including
156 NSW and 122 QLD hospitals. During the 2-week
recruitment period, 91 NSW and 61 QLD hospitals
recruited suspected ACS patients. Ethics approval for opt-
out consent was obtained from all participating centers.
Data collection
Patients found to be alive at hospital discharge were
followed-up by phone/paper survey at approximately
18 months after their index admission. The question-
naire was adapted from a previous study [12]. Paper
surveys were posted to the entire cohort and data was
entered into a custom built database. Non-responders
were followed up by telephone and data was entered
directly into the database during the call. The phone
survey was conducted using a formal script that was the
same as the paper survey. In brief, the questionnaire
included information on demographic, education, em-
ployment, out-of-pocket expenditure and household
economic situation. The follow-up data were then linked
to the subset of baseline data from SNAPSHOT ACS.
The baseline data collected included demographics,
presenting clinical characteristics, receipt of evidence
based medication and coronary revascularization. The
patient risk at presentation was estimated using the
Global Registry of Acute Coronary Events (GRACE) risk
score, a score proved to have high capacity to predict
mortality [16]. The GRACE risk score was grouped into
three risk categories, consistent with the European
Society of Cardiology Guideline (low: ≤108, intermedi-
ate: 109–140, high >140) [17]. To determine the patient’s
socioeconomic status (SES), the postcode of each patient
was linked to the Index of Relative Socio-economic
Disadvantage (IRSD) score from the Australian Socio-
Economic Indexes for Areas (SEIFA) [18]. A low score
indicates that the area of residence has relatively greater
socioeconomic disadvantage. The IRSD tenths provided
by the Australian Bureau of Statistics were used to
define five groups for the current analyses.
Outcomes
The outcomes explored were out-of-pocket expenditure
on healthcare and household economic hardship (hard-
ship here after). The out-of-pocket expenditure was the
amount spent on managing the medical condition includ-
ing medical services, medications, ambulance/transport,
exercise/allied health, home and self-care assistance and
special foods, in the previous 3 months from the time of
18-month follow-up which was not covered by Medicare
or private health insurance. A period of 3 months was
used to observe the out-of-pocket expenditure as it was
considered to be a long enough time period to capture the
fluctuation of the expenditure for medical care and treat-
ment over time, but at the same time, a short enough time
for patients to recall the expenditures without too much
burden. This approach of 3-month recall has been
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employed in other studies [12, 13]. The expenditure was
then converted to monthly expenditure. The collection
and analyses of out-of-pocket expenditure were done in
Australian Dollars. Hardship was measured using a series
of questions about the household’s inability to pay living
or medical expense or the use of financial coping strat-
egies (e.g. drew on accumulated savings or sought finan-
cial assistance) in order to pay a living expense in the
previous 12 months, as defined in a previous study [12].
Variables related to income or socioeconomic status was
not used to define hardship as household economic
hardship can potentially affect individuals of all socioeco-
nomic status. Patients were categorized into the hardship
group if they reported to have difficulties paying at least
one expense or used any one or more of the financial
coping strategies.
Statistical analysis
Unadjusted analyses were performed between the patient
specific characteristics and the two outcomes: the
amount of expenditure and hardship. To compare cat-
egorical variables Chi-squared test was used, to compare
means between two groups, independent t-test was used,
and to compare a continuous variable with a skewed dis-
tribution and a categorical variable Wilcoxon rank-sum
test (for two groups) and Kruskal-Wallis test (for three
groups) were used. The zero-inflated negative binomial
model was used to derive the relative rates (RRs), the
corresponding 95 % confidence intervals (CIs) and the
p-values for the factors associated with the amount of
out-of-pocket expenditure. A multiple-adjusted logistic
regression model was used to predict factors associated
with hardship. The odds ratios (ORs), the corresponding
95 % CIs were estimated and the p-values derived.
Candidate variables for both models comprised of those
which were statistically significant at α = 0.2 on univari-
able comparisons. Variables included in the negative
binomial regression model predicting the out-of-pocket
expenditure were: age (18–59, 60–69, 70–79 and
≥80 years), revascularization from baseline, and private
health insurance status, employment status and pen-
sioner concession card at follow-up. Variables included
in the logistic regression model to predict hardship: age
(categorized as above), SES (IRSD in five groups),
GRACE risk categories, smoking status, hypertension
and prior cardiovascular disease (CVD) from baseline,
and private insurance, employment status, pensioner
concession card and out-of-pocket spending (in four
groups) at follow-up. Other demographic and clinical
characteristics were also explored, however, were not
included in the models as they did not meet the level of
significance in the univariate analyses. Data were
analyzed using SAS 9.4 (SAS Institute Inc. Cary, North
Carolina, United States).
Results
Of 3381 Australian patients from 251 participating
hospitals who participated in SNAPSHOT ACS, 1833
had ACS and were admitted to one of the 152 NSW/
QLD hospitals and were therefore included in this
present analysis. Excluding 180 (10 %) patients who died
in hospital and after discharge, 1653 (90 %) NSW/QLD
patients were contacted for follow-up at 18 months. Of
those, 702 (42 %) responded and agreed to complete the
survey relating to household economic status. Patients
who have completed the survey had the mean age of
65 years (SD (standard deviation): 13), 431 (61 %) were
male, and 263 (37 %) had private health insurance at
baseline. The median GRACE risk score for these
patients was 94 (IQI (inter-quartile interval): 74–118),
339 (48 %) patients had prior cardiovascular disease, 156
(53 %) had revascularization and 98 (14 %) had an
in-hospital event.
Out-of-pocket expenditure
In total, 92 % (n = 614) of patients reported that they
had out-of-pocket expenditure. The mean out-of-pocket
expenditure in the 3-month period prior to the
18-month follow-up was A$258.06 (SD: A$405.38) per
month (Table 1). Of those with out-of-pocket expenditure,
90 % spent on medication, 51 % on medical services
(general practitioner, physician specialist, hospitalization
and medical test) and 26 % on ambulance/transport. The
mean spending for medical services was A$120.18 (SD:
A$310.35), medication was A$66.25 (SD: A$80.78), ambu-
lance/transport was A$30.95 (SD: A$130.53) and exercise/
allied health was A$15 (SD: A$55).
Factors associated with out-of-pocket expenditure
Patient factors associated with the amount of out-of-
pocket expenditure were predicted. After adjustment,
younger patients (18–59 vs. ≥80 years (RR (95 % CI)):
1.80 (1.16, 2.77); 60–69 vs. ≥80 years: 1.63 (1.18, 2.25);
and 70–79 vs. ≥80 years: 1.75 (1.29, 2.38); p = 0.005) with
private health insurance ((RR (95 % CI)): 1.57 (1.30, 1.91);
p < .0001) were more likely to have higher expenses.
Household economic hardship
In total, 350 (51 %) respondents reported that they had
experienced hardship. That included, 78 (12 %) reporting
they were unable to pay for medical consultations/tests,
81 (12 %) for medications, 109 (17 %) for dental appoint-
ments, 77 (12 %) for rent or mortgage, 39 (6 %) for
meals and 101 (15 %) for utility bills on time. In
addition, 221 (34 %) drew on accumulated savings, 61
(9 %) sought financial assistance from welfare/community
organization and 71 (11 %) sought financial assistance
from friends/family.
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Factors associated with hardship
The characteristics of patients with hardship at
18 months are shown in Table 2. Younger patients (OR
for 18–59 vs. ≥80 years: 1.89; 60–69 vs. ≥80 years: 1.64;
70–79 vs. ≥80 years: 0.69), without private health insur-
ance (OR: 2.04), with a pensioner concession card (OR:
1.80), residing in a more disadvantaged area (OR for
group 1 vs. 5: 1.77; group 2 vs. 5: 2.30; group 3 vs. 5:
1.31; group 4 vs. 5: 0.92), had history of CVD (OR: 1.47)
and with higher out-of-pocket expenditure (OR for
group 2 vs. 1: 1.61; group 3 vs. 1: 2.68; and group 4 vs. 1:
4.57) had greater likelihood of experiencing hardship
(Table 3).
Discussion
This is one of the first known studies to explore the
household economic burden for Australians living with
heart disease. Results indicate that 50 % of ACS survi-
vors experience substantial household economic burden
associated with their illness. On average patients with
ACS were spending A$258 per month on health care re-
lated out-of-pocket costs. In total, half of the responders
to the survey reportedly experienced hardship in the last
12 months prior to the follow-up. Patients who were
more likely to have higher out-of-pocket expenditure
were those who were older and those with private health
insurance. Similar to other studies, hardship was signifi-
cantly associated with both younger and advanced age,
no private health insurance, pensioner concession card,
residence of a more disadvantaged area, history of CVD
and greater out-of-pocket expenses [19, 20].
Our findings show a substantial monthly out-of-
pocket expense following an ACS event, which was
greater than the average estimated out-of-pocket health
spending in Australia in 2010–11 of A$90 per month,
per person [21], the UK in 2013 of $196 per month, per
person [22], and the US in 2011 of $101 for 65 years or
older patients per month, per person [23]. We also
found that a relatively large proportion of patients in our
cohort were unable to pay for medical consultations/
tests (12 %) and prescription or non-prescription medi-
cations (12 %). Similar findings have been reported for
other chronic disease areas [12, 13, 24]. For patients with
COPD, 25 % reported that they were unable to pay for
medical or dental consultations and tests and 18 % for
medications, and for CKD patients, 14 % could not for
medical appointments and 19 % for medications [12, 13].
The findings suggest that in spite of patients reporting
high levels of expenditure on ongoing treatment, there are
many patients who report instances where they have
foregone treatment due to cost. The policy argument
strengthening coverage for out-of-pocket costs is therefore
justified as these costs reinforce economic disadvantages
in patients with this condition and in addition, represent a
significant barrier to optimal management of ACS.
National and international guidelines continue to
emphasize the importance of evidence-based medica-
tions, along with lifestyle advice and participation in car-
diac rehabilitation program for secondary prevention
[25]. It is well known that an opposing relationship ex-
ists between non-adherence to medications and associ-
ated health care cost [26]. It was found that missing
doctors’ appointments and sub-optimal communication
between clinicians and patient can also lead to non-
adherence to medication [27]. Whilst Medicare provides
extensive subsidies on prescription medicines and non–
hospital medical services and free public hospital care
there is a growing recognition that the burden of out-of-
pocket costs is significant, particularly for individuals
with long term and chronic conditions [28]. The main
drivers of these costs are likely to be the need for on-
going multiple medicines and follow-up treatment for
people with ACS, and high gap payments (the difference
provided by government and the full cost which is cov-
ered out-of-pocket) particularly for medical (or phys-
ician) specialist consultations.
Table 1 Out-of-pocket expenditure (per month)
Items Mean A$ (SD) for patients
with any OOP expenditure
on at least one of the items
Median A$ (IQI) for patients
with any OOP expenditure
on at least one of the items
n (%) patients with
any OOP expenditure
on the specific item
Median A$ (IQI) for patients
with any OOP expenditure
on the specific item
Medical service 120.18 (310.35) 10.33 (0.00, 100.00) 277 (51) 100.00 (46.67, 258.33)
Medications 66.25 (80.78) 44.67 (26.67, 73.00) 487 (90) 50.00 (33.33, 80.00)
Ambulance/Transport costs 30.95 (130.53) 0.00 (0.00, 8.33) 142 (26) 40.00 (18.67, 133.33)
Exercise/allied health 16.68 (66.28) 0.00 (0.00, 0.00) 78 (14) 81.67 (40.00, 133.33)
Home and self-care assistance 14.14 (81.90) 0.00 (0.00, 0.00) 50 (9) 84.00 (40.00, 144.00)
Special foods 5.66 (52.95) 0.00 (0.00, 0.00) 19 (4) 66.67 (33.33, 133.33)
Other 4.20 (58.23) 0.00 (0.00, 0.00) 10 (2) 58.33 (30.00, 120.00)
Total expenditure 258.06 (405.38) 126.50 (50.00, 280.00) 540 (100) 126.50 (50.00, 280.00)
Out-of-pocket expenditures are in Australian Dollars
SD standard deviation, IQI inter-quartile interval, OOP out-of-pocket
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This study has limitations. As an observational design
was used, reporting bias may have been introduced. Also,
the response rate to the follow-up study was relatively
low; however, assessment of the patient characteristics at
baseline and follow-up were similar between NSW/QLD
participants and those who were lost to follow-up as well
as the rest of the Australian patients. Further, compared
to the previous studies that collected similarly detailed
and personal data, aiming to find the household economic
hardship in other chronic areas, 702 would be considered
sizable and well powered to detect important predictors of
the household economic hardship such as age, conces-
sional status, and health insurance status [12, 13]. Also,
the SNAPSHOT ACS study collected data on a represen-
tative and diverse cohort over a 2-week period from more
than 200 hospitals across Australia using the opt out
methods of consent. Therefore, although the sample size
seems modest, the results are generalizable. As patients
were asked to provide out-of-pocket expenditure over a
3-month period, it is likely that it was underestimated and
be subjected to recall bias. The out-of-pocket expenditure
may not have been related to ACS management only, but
also for other major comorbidities including diabetes,
heart failure, chronic renal failure and major bleeding.
However, as ample number of ACS patients manage
comorbidities, our estimates reflect the expenditures in
reality. Also, when predicting the factors associated with
household economic hardship, variables such as prior
cardiovascular diseases and out-of-pocket expenditure,
which takes into account the costs of comorbidities, were
included as independent variables to adjust for comorbidi-
ties. In addition, data was collected via self-report and
findings need to be considered accordingly.
Conclusion
In this cohort, we examined the out-of-pocket expenses
and household economic situation. The results indicate
Table 2 Baseline characteristics and in-hospital management
for household economic hardship
Hardship
(n = 350, 51 %)
No-hardship
(n = 331, 49 %)
P-value
Age, mean (SD) 63 (14) 67 (12) 0.0001
Age
18–59 years 138 (39) 93 (28) 0.0006
60–69 years 96 (27) 81 (24)
70–79 years 71 (20) 108 (33)
80+ years 45 (13) 49 (15)
Male 224 (64) 197 (60) 0.2287
No private insurance 224 (67) 162 (49) <.0001
Work status at 18 months
Employed 79 (24) 90 (28) <.0001
Unemployed 61 (19) 18 (6)
Retired 186 (57) 213 (66)
Education
No education or primary
school only
49 (15) 47 (15) 0.9233
Secondary school only 152 (46) 152 (48)
TAFE diploma or certificate 74 (22) 65 (20)
University degree 55 (17) 56 (18)
Pensioner concession card 222 (67) 195 (59) 0.0425
IRSD (5 groups)
1 (most disadvantaged) 72 (21) 48 (15) 0.0028
2 104 (30) 72 (22)
3 80 (23) 83 (25)
4 57 (16) 81 (24)
5 (least disadvantaged) 35 (10) 47 (14)
Medical history
GRACE risk score
(risk categories)
Low 237 (68) 203 (61) 0. 0528
Intermediate 91 (26) 94 (28)
High 20 (6) 34 (10)
Current smoker 74 (21) 36 (11) 0.0003
Hypertension 225 (64) 197 (60) 0.2001
Hyperlipidemia 202 (58) 186 (56) 0.6887
Diabetes 93 (27) 77 (23) 0.3187
Prior CVDa 180 (51) 148 (45) 0.0796
Other Comorbiditiesb 63 (18) 49 (15) 0.2607
Diagnosis
STEMI 28 (8) 38 (11) 0.4650
NSTEMI 62 (18) 60 (18)
UA 91 (26) 84 (25)
Other 169 (48) 149 (45)
Table 2 Baseline characteristics and in-hospital management
for household economic hardship (Continued)
In-hospital management
Cardiac catheterization 140 (40) 142 (43) 0.4425
Revascularizationc 74/140 (53) 78/142 (55) 0.7270
4 or more EBM at discharge 164 (47) 149 (45) 0.6297
In-hospital events
In hospital eventsd 52 (15) 44 (13) 0.5577
Data are shown as frequency and proportion (%) unless otherwise specified
SD standard deviation, IRSD index of relative socio-economic disadvantage,
GRACE global registry of acute coronary events, IQI inter-quartile interval, CVD
cardiovascular disease, PCI percutaneous coronary intervention, CABG coronary
artery bypass graft, STEMI ST elevation myocardial infarction, NSTEMI non-ST
elevation myocardial infarction, UA unstable angina, EBM evidence
based medications
aPrior CVD: prior myocardial infarction, prior peripheral vascular disease, prior
stroke, prior PCI, prior CABG or prior atrial fibrillation
bOther Comorbidities: prior renal failure, prior major bleeding, prior active
cancer, prior dementia or prior impaired mobility
cRevascularization: PCI or CABG
dIn hospital events: myocardial infarction, stroke, heart failure, renal failure,
major bleeding or cardiac arrest
Hyun et al. BMC Health Services Research  (2016) 16:636 Page 5 of 8
that along with the high risk medical condition, ACS
brings excess out-of-pocket expenditure compared to
the national average expenditure. Further, a sizable sub-
set of ACS survivors experiences a substantial household
economic burden and that half of the cohort experi-
enced at least once incidence of hardship in the previous
12 months. These findings suggest that out-of-pocket
costs pose a significant barrier to optimal management
of patients with ACS and more broadly, contribute to
exacerbating economic disadvantage amongst household
with individuals with chronic disease.
Appendix
Participating hospitals
New South Wales
Hospital; Armidale Rural Referral Hospital; Ballina
District Hospital; Balmain Hospital; Balranald District
Hospital; Bankstown Lidcombe Hospital; Baradine MPS;
Barham Health Service; Barraba MPS; Bateman’s Bay
District Hospital; Bathurst Health Service; Batlow
Adelong MPS; Bega Hospital; Bellingen River District
Hospital; Belmont Hospital; Berrigan Health Service;
Bingara MPS; Blayney District Hospital; Boggabri MPS;
Bombala MPS; Boorowa Health Service; Bourke District
Hospital; Bowral Hospital; Braidwood MPS; Brewarrina
MPS; Broken Hill Base Hospital; Bulahdelah Community
Hospital; Byron District Hospital; Calvary Health Care
Riverina; Calvary Mater Newcastle; Campbelltown Hospital;
Canterbury Hospital; Casino & District Memorial Hospital;
Cessnock District Hospital; Cobar Health Service; Coffs
Harbour Health Campus; Collarenebri Health Service;
Concord Repatriation General Hospital; Condobolin
District Hospital; Coolah MPS; Coolamon MPS; Cooma
Hospital; Coonamble Health Service; Cootamundra
Hospital; Corowa Health Service; Cowra District Hospital;
Crookwell District Hospital; Culcairn Health Service;
Delegate MPS; Deniliquin Hospital; Denman MPS;
Dorrigo MPS; Dubbo Base Hospital; Dunedoo MPS;
Dungog Community Hospital; Fairfield Hospital; Finley
Hospital; Forbes District Hospital; Gilgandra MPS; Glen
Innes Health Service; Gloucester District Health Service;
Goodooga Hospital; Gosford Hospital; Goulburn Base
Hospital; Grafton Base Hospital; Grenfell MPS; Griffith
Base Hospital; Gulargambone MPS; Gulgong Health
Service; Gunnedah District Health Service; Hay Hospital;
Henty MPS; Hillston Hospital; Inverell Hospital; John
Hunter Hospital; Junee MPS; Kempsey Health Campus;
Kurri Kurri Hospital; Kyogle Hospital; Lake Macquarie
Private Hospital; Leeton Health Service; Lismore Base
Hospital; Liverpool Hospital; Lockhart Health Facility;
Macksville Health Campus; Maclean Hospital; Maitland
Hospital; Manilla MPS; Manly Hospital; Manning Rural
Table 3 Multiple-adjusted odds ratios and 95 % confidence intervals for household economic hardship vs. no-hardship
Hardship vs. no-hardship Odds ratio (95 % confidence interval) P-value
Age 18–59 years vs. 80+ years 1.89 (0.77, 4.63) 0.0130
60–69 years vs. 80+ years 1.64 (0.81, 3.34)
70–79 years vs. 80+ years 0.69 (0.38, 1.27)
No private insurance vs. private insurance 2.04 (1.37, 3.03) 0.0005
Employment status Unemployed vs. employed 2.06 (0.97, 4.39) 0.1087
Retired vs. employed 1.01 (0.51, 1.99)
Pensioner Concession card 1.80 (1.03, 3.18) 0.0406
IRSDa Group 1 vs. 5 1.77 (0.91, 3.45) 0.0043
Group 2 vs. 5 2.30 (1.23, 4.30)
Group 3 vs. 5 1.31 (0.70, 2.45)
Group 4 vs. 5 0.92 (0.48, 1.75)
GRACE risk category Intermediate vs. low 1.24 (0.76, 2.01) 0.0940
High vs. low 0.55 (0.25, 1.24)
Current smoker vs. ex-smoker 1.67 (0.98, 2.82) 0.0576
Hypertension vs. not 1.21 (0.83, 1.76) 0.3144
Prior CVD vs. not 1.47 (1.00, 2.14) 0.0477
Out-of-pocket expenditureb Group 2 vs. 1 1.61 (0.98, 2.64) <.0001
Group 3 vs. 1 2.68 (1.62, 4.43)
Group 4 vs. 1 4.57 (2.71, 7.70)
IRSD index of relative socio-economic disadvantage, GRACE global registry of acute coronary events, CVD cardiovascular disease
aGroup 1 is the most disadvantaged and Group 5 is the least disadvantaged
bGroup 1 had lowest out-of-pocket expenditure and Group 4 had highest expenditure
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Referral Hospital (Taree); Menindee Health Service;
Merriwa MPS; Milton-Ulladulla Hospital; Moree District
Health Service; Moruya District Hospital; Mudgee Health
Service; Mullumbimby Hospital; Murrumburah-Harden
Health Service; Muswellbrook District Health Service;
Narrabri District Health Service; Narrandera Health
Service; Narromine Health Service; Newcastle Private
Hospital; Nyngan MPS; Tomaree Community Hospital
(Nelson Bay); North Shore Private Hospital; Oberon
Health Service; Orange Health Service; Pambula District
Hospital; Parkes Health Service; Peak Hill Health Service;
Port Macquarie Base Hospital; Prince of Wales Hospital;
Prince of Wales Private Hospital; Queanbeyan Hospital;
Quirindi Community Hospital; Royal North Shore
Hospital; Royal Prince Alfred Hospital; Ryde Hospital;
Scott Memorial Hospital (Scone); Shellharbour Hospital;
Shoalhaven District Memorial Hospital; Singleton District
Hospital; St George Hospital; St George Private Hospital;
Strathfield Private Hospital; Sutherland Heart Clinic;
Tamworth Rural Referral Hospital; Temora Hospital;
Tenterfield Community Hospital; Tibooburra District
Hospital; Tocumwal Hospital; Tottenham MPS; Trangie
MPS; Trundle MPS; Tullamore MPS; Tumbarumba MPS;
Tumut Health Service; Urana MPS; Urbenville Health
Service; Vegetable Creek Hospital (Emmaville); Wagga
Wagga Base Hospital; Walcha MPS; Walgett Health
Service; Warialda MPS; Wee Waa Community Hospital;
Wellington Health Service; Werris Creek Health
Service; Westmead Private Hospital; Wilcannia MPS;
Wilson Community Hospital (Murrurundi); Wollongong
Hospital; Wyalong Hospital; Wyong Hospital; Yass
District Hospital; Young District Hospital.
Queensland
Allamanda Private; Alpha Hospital; Atherton Hospital;
Augathella Hospital; Ayr Hospital; Babinda Hospital;
Bamaga Hospital; Baralaba Hospital; Barcaldine Hospital;
Beaudesert Hospital; Biggenden Hospital; Biloela Hospital;
Blackall Hospital; Blackwater Hospital; Boonah Hospital;
Bowen Hospital; Bundaberg Friendly; Bundaberg Hospital;
Caboolture Hospital; Cairns Base Hospital; Cairns Private;
Caloundra Hospital; Capricorn Coast Hospital; Charleville
Hospital; Charters Towers Hospital; Cherbourg Hospital;
Childers Hospital; Chinchilla Hospital; Clermont Hospital;
Collinsville Hospital; Cooktown Hospital; Cloncurry
Hospital; Dalby Hospital; Dirranbandi Hospital; Doo
madgee Hospital; Eidsvold Hospital; Emerald Hospital;
Esk Hospital; Dysart Hospital; Gatton Hospital; Gayndah
Hospital; Gin Gin Hospital; Gladstone Hospital; Gold
Coast Hospital; Goondiwindi Hospital; Greenslopes
Private; Gympie Hospital; Hervey Bay Hospital; Hillcrest
Private Hospital; Hughenden Hospital; Ingham Hospital;
Inglewood Hospital; Innisfail Hospital; Ipswich Hospital;
John Flynn; Jandowae Hospital; Kilcoy Hospital; Joyce
Palmer Hospital; Julia Creek Hospital; Laidley Hospital;
Logan Hospital; Longreach Hospital; Mackay Base Hospital;
Maleny Hospital; Mareeba Hospital; Maryborough Hospital;
Mater Adult Public Hospital; Mater Private Brisbane; Mater
Private Mackay; Mater Private Rockhampton; Mater Private
Townsville; Miles Hospital; Millmerran Hospital; Mitchell
Hospital; Monto Hospital; Moranbah Hospital; Mornington
Island Hospital; Mossman Hospital; Mount Isa Hospital;
Mount Morgan Hospital; Moura Hospital; Mundubbera
Hospital; Mungindi Hospital; Murgon Hospital; Nambour
Hospital; Nambour Selengor; Nanango Hospital; Norm
anton Hospital; Princess Alexandra Hospital; Proserpine
Hospital; Queen Elizabeth II Jubilee Hospital; Quilpie
Hospital; Redcliffe Hospital; Redland Hospital; Richmond
Hospital; Rockhampton Base Hospital; Roma Hospital;
Royal Brisbane & Women’s Hospital; Sarina Hospital;
St Andrew’s Private Toowoomba; St Andrew’s War
Memorial, Brisbane; St George Hospital; St Vincent’s
Hospital; Springsure Hospital; Stanthorpe Hospital;
Sunshine Coast Private Hospital; Surat Hospital; Tara
Hospital; Texas Hospital; Theodore Hospital; The Prince
Charles Hospital; Thursday Island Hospital; Toowoomba
Hospital; Townsville Hospital; Tully Hospital; Warwick
Hospital; Weipa Hospital; Winton Hospital; Wesley
Hospital; Woorabinda Hospital; Wynnum Hospital;
Yarrabah Hospital.
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RR: Relative rate; SD: Standard deviation; SEIFA: Socio-economic indexes for
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